Director of cellular immunotherapy at Massachusetts General Hospital and associate professor at Harvard Medical School. Her laboratory focuses on creating next-generation CAR T-cells (chimeric antigen receptor T-cells). Dr. Maus trained with Carl June, M.D. at the University of Pennsylvania and is a pioneer in the field of cancer immunology with particular expertise in T-cell immunotherapies.